HOME | CONTACT

See Nektar's R&D pipeline of products in clinical development »
Learn more about our clinical trials »
See Nektar partners and case studies »
News Headlines
January 05 Baxter Initiates Phase I Clinical Trial of Longer-Acting Recombinant FVIII Treatment for Hemophilia A »
Events Calendar
May 2, 2012 Nektar Therapeutics Q1 2012 Financial Results Call
2:00 PM Pacific Time
Listen to this webcast
Replay Dial-in Information:
U.S. (888) 286.8010
International (617) 801.6888
Passcode: 29485870
Apr. 16, 2012 Nektar Investor and Analyst R&D Day
12:00 pm to 5:00 pm ET
New York City
Listen to this webcast
View Presentation Part 1
View Presentation Part 2
Mar. 6, 2012 Cowen and Company’s 32nd Annual Health Care Conference
10:00 AM Eastern Time
Listen to this webcast
View Presentation
Media Highlights
BioCentury features Phase 1 NKTR-181 data in the Bernstein Report on BioBusiness
Drug Discovery News interviews Nektar's chief medical officer, Dr. Robert Medve, on NKTR-181 Phase 1 Data
Dr. Agustin Garcia presents NKTR-102 data in an oral abstract session at the 2011 ASCO Breast Cancer Symposium
Watch video clip »
 
Site Map Privacy Terms of Use Compliance Policy Trademarks Site Users Guide Copyright Nektar © 2012